Progressive Corporation (PGR)

Total Non-Current Assets

$108.28B

Quarterly · Period ending: · USD

PGR logo

PGR Total Non-Current Assets

Latest reported$108.28B
PGR Quarterly Non-Current Assets ($810.80M → $108.28B)
High-resolution chart · PNG

PGR total non-current assets history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Progressive Corporation Total Non-Current Assets — Quarterly (USD)
Period endingTotal Non-Current Assets (USD)
108,282,000,000
105,446,000,000
95,139,000,000
82,878,000,000
90,338,000,000
820,000,000
854,000,000
82,425,000,000
1,286,800,000
3,228,200,000
3,247,300,000
9,136,000,000
3,574,200,000
3,442,800,000
9,022,900,000
9,203,400,000
9,220,600,000
9,059,500,000
10,811,500,000
11,291,900,000
10,260,400,000
10,217,900,000
9,925,900,000
9,444,800,000
8,794,400,000
8,298,200,000
11,088,400,000
8,262,500,000
11,536,100,000
11,178,100,000
10,649,200,000
9,791,300,000
9,813,200,000
9,668,300,000
9,281,700,000
9,739,300,000
10,004,600,000
9,107,100,000
9,047,500,000
8,719,600,000
8,766,300,000
8,367,400,000
8,122,800,000
7,904,000,000
7,624,900,000
7,681,800,000
6,416,100,000
6,358,200,000
6,097,000,000
6,053,200,000
6,241,900,000
6,134,500,000
5,880,800,000
5,755,900,000
5,620,200,000
5,501,500,000
17,366,800,000
17,433,300,000
17,355,700,000
5,378,400,000
17,106,500,000
17,245,100,000
17,227,000,000
16,885,100,000
4,847,300,000
16,853,300,000
16,709,100,000
16,286,500,000
15,942,500,000
15,182,100,000
14,209,200,000
14,623,000,000
15,250,900,000
15,812,700,000
14,604,900,000
15,990,000,000
16,236,300,000
17,699,000,000
16,685,500,000
16,307,600,000
15,977,100,000
16,098,000,000
15,798,900,000
15,515,000,000
15,486,700,000
13,529,800,000
14,073,100,000
13,380,400,000
13,438,200,000
14,128,000,000
13,656,900,000
13,155,800,000
13,237,900,000
11,756,300,000
11,262,200,000
11,140,200,000
10,206,400,000
10,001,600,000
9,497,400,000
9,107,600,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.